Academia Sinica develops new antibody able to kill cancer cells

11/16/2020 08:32 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, Nov. 16 (CNA) A research team at Taiwan's top academic research institution has developed a new antibody tool that has shown promising results in killing malignant tumor cells in mice and could eventually be turned into a therapeutic drug.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.